Home » Trials » SLCTR/2013/021


Oral hypoglycaemic and anti-inflammatory activity of P.ostreatus and P.cystidiosus on diabetic subjects, who are on diet control

-

SLCTR Registration Number

SLCTR/2013/021


Date of Registration

24 Jun 2013

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Oral hypoglycaemic and anti-inflammatory activity of P.ostreatus and P.cystidiosus on diabetic subjects, who are on diet control


Public Title of Trial

Oral hypoglycaemic activity of Pleurotus mushrooms on diabetic subjects


Disease or Health Condition(s) Studied

Diabetes mellitus


Scientific Acronym

None


Public Acronym

None


Brief title

Oral hypoglycaemic activity of Pleurotus mushrooms on diabetic subjects


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

380/8 and 599/11 (Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura)


Trial Details


What is the research question being addressed?

What is the effect of a single dose of culinary P. ostreatus and P. cystidiosus mushrooms on the blood sugar of diabetic patients on diet control?


Type of study

Interventional


Study design

Allocation

Non-randomized controlled trial


Masking

Masking not used


Control

Placebo


Assignment

Crossover


Purpose

Treatment


Study Phase

Not Available


Intervention(s) planned

All patients who present to the Family Practice Centre, Faculty of Medical Sciences, University of Sri Jayewardenepura within the inclusion criteria will be considered for the study.

Consenting patients will be divided into 2 groups. Group 1 will receive P. ostreatus and group 2 will receive P. cystidiosus.

On day 1, patients will receive a placebo (distilled water). Glucose load will be given 30 minutes after administration of the placebo. Standard glucose tolerance test will be performed. (75 g glucose in 300 ml water).Blood samples (3ml) will be collected by venepuncture, 2 hours after the glucose load, for the estimation of blood glucose concentrations.

On day 8, a single dose of freeze dried and powdered P. ostreatus or P. cystidiosus at a dose of 50 mg/kg will be administered. The mushroom will be administered as a suspension in water to each patient according to their respective group.

Glucose load will be given 30 minutes after administration of the mushroom suspension. Standard glucose tolerance test will be performed.

At the end of 4 weeks, liver function and renal function will be determined.


Inclusion criteria

  1. Type 2 diabetic patients
  2. On diet control only
  3. Ability to read and understand Sinhala and English

Exclusion criteria

  1. Type 1 diabetics
  2. Pregnancy /breastfeeding
  3. Patients on any oral hypoglycaemic medication
  4. Patients on insulin
  5. Patients on herbal medications known to have an effect on blood glucose


Primary outcome(s)

1.

Fasting blood glucose

[

Prior to administration of the mushroom suspension

]
2.

Post glucose loaded (OGTT) blood glucose

[

2 hours after glucose load.

]
3.

Serum insulin levels (using ELIZA kits)

[

2 hours after glucose load.

]

Secondary outcome(s)

1.

Change in liver function : serum alanine amino transferase, aspartate amino transferase, alkaline phosphatase, gamma glutamyl transpeptidase

[

At base line and at the end of 4 weeks

]
2.

Change in renal function : serum creatinine

[

At baseline and at the end of 4 weeks

]

Target number/sample size

28 patients (14 in each group)


Countries of recruitment

Sri Lanka


Anticipated start date

2013-07-01


Anticipated end date

2013-08-31


Date of first enrollment

2013-06-25


Date of study completion


Recruitment status

Recruiting


Funding source

World Class University Project, University of Sri Jayewardenepura, WCUP PhD/04/2012


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2012-03-29


Approval number

599/11


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address:Gangodawila, Nugegoda Sri Lanka
Telephone:+94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Sugandhika Suresh
Senior Lecturer
Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura

077731456


malalavidhane@yahoo.com

Contact Person for Public Queries

Dr. Sugandhika Suresh
Senior Lecturer
Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura

077731456


malalavidhane@yahoo.com


Primary study sponsor/organization

University of Sri Jayewardenepura

Gangdawilla, Nugegoda
0112802696


unisj@sjp.ac.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results